Grossman Receives Highest Honor for Pioneering Scientific Contributions to Magnetic Resonance in Medicine and Biology from International Society for Magnetic Resonance in Medicine. Grossman also receives Penn Medicine 2010 Distinguished Graduate and University of Bordeaux’s Doctor Honoris Causa
May is Melanoma Awareness Month—calling attention to a disease that kills one American every hour. Melanoma however, if detected early, can often be successfully treated. Melanoma experts at NYU Langone Medical Center's Ronald O. Perelman Department of Dermatology and the NYU Cancer Institute, are available to discuss melanoma, including the best ways to identify a suspicious mole, how to prevent and reduce the risk of the disease, and current treatments and therapies, including a potential melanoma vaccine.
Researchers at NYU Langone Medical Center have created stem cells from the eggs of aging mice that could be used for reproductive purposes and regenerative medicine. The study, published in April issue of Aging Cell, found that even though the eggs from older females were slightly less efficient at making stem cells than those from younger females, the capacity to create stem cells was sustained.
Researchers from NYU Langone Medical Center have discovered and characterized a general mechanism that controls transcription elongation in bacteria. The mechanism, described in the April 23 issue of Science, relies on physical cooperation between a moving ribosome and RNA polymerase (RNAP) that allows for a precise adjustment of the transcriptional yield in response to translational needs. The study could lead to the development of new ways to interfere with bacterial gene expression and serve as a new target for antimicrobial therapy.
On Saturday, April 24, 2010, families throughout New York City will have a rare opportunity to learn about new breakthroughs and emerging treatments in mental health from some of the nation’s best and brightest mental health researchers. The NYU Child Study Center of NYU Langone Medical Center will join more than 40 other institutions nationwide to partner with NARSAD in presenting its “Healthy Minds Across America” series of public talks. Each event brings science to families seeking hope for better treatments of a broad range of mental illnesses.
NYU Langone Medical Center researchers have developed a powerful new method to investigate the discrete steps necessary to turn on individual genes and examine how the process goes wrong in cancer and other diseases. The finding, based on seven years of research and described in the April 9 issue of Molecular Cell, allows scientists to investigate the unfolding of DNA, a process required for gene activation.
By enhancing the activity of immune cells that protect against runaway inflammation, researchers at NYU Langone Medical Center may have found a novel therapy for rheumatoid arthritis and other autoimmune diseases. In a new study published in the March 25, 2010 online edition of Science, the researchers reveal how treating these immune cells with an investigational drug wards off inflammation by holding a particular enzyme at bay.
The Biotechnology Study Center of NYU School of Medicine will hold its annual awards symposium on April 5, 2010, to honor three outstanding leaders in biomedical research. The Dart/NYU Biotechnology Achievement Awards recognize the role of pure science in the development of pharmaceuticals and honors those scientists whose work has led to major advances to improving care provided at the patient’s bedside.
A family history of Alzheimer’s is one of the biggest risk factors for developing the memory-robbing disease, which affects more than 5 million Americans and is the most common form of senile dementia. Now an international collaboration led by NYU Langone Medical Center researchers has found the likely basis for this heightened familial risk—especially from the maternal side.
Joseph Zuckerman, MD, Walter A. L. Thompson Professor of Orthopaedic Surgery and chair, department of orthopedic surgery at NYU Langone Medical Center Hospital for Joint Diseases, will present at the annual meeting of the American Academy of Orthopaedic Surgeons (AAOS), March 9-13 at the Morial Convention Center in New Orleans, and joined by other orthopaedic surgeons from the medical center.
Researchers at NYU School of Medicine have found that elevated cerebrospinal fluid levels of phosphorylated tau231 (P-tau231), a damaged tau protein found in patients with Alzheimer’s disease, may be an early diagnostic biomarker for Alzheimer’s disease in healthy adults.
The 2009 Gold eHealthcare Leadership Award has been awarded to NYU Langone Medical Center’s educational website and blog, “Clinical Correlations,” under the direction of Editor In Chief Neil Shapiro, MD. This ten year old awards program instituted by Strategic Health Care Communications, a business development and marketing firm for Health Care Executives, attracts over 1100 entrants and is the largest web-oriented awards program focused exclusively on healthcare. “Clinical Correlations” won the award in the Best Health/ Healthcare Content –Physician/Clinician Focused Site category just as it is celebrating its third anniversary of publication.
Dr. Harry Ostrer, professor of pediatrics, pathology and medicine at NYU Langone Medical Center will be conducting genetic screening at four college campuses in Boston on February 1st and 2nd. Individuals interested in being screened must sign-up online at www.med.nyu.edu/genetics.
1) Heart Fair by NYU Cardiac & Vascular Institute; 2) Women Versus Men When It Comes to Heart Attack; 3) Know Your Numbers; 4) Cutting Down on Salt Can Prevent Heart Disease; 5) Breakthrough Imaging Technology is Helping Cardiologists and Surgeons Better Treat Heart Disease...
A new study led by researchers at NYU Langone Medical Center is shedding new light on the action of Rho, a key regulatory protein in E. coli and many other bacteria. The study reveals a new paradigm to understand the molecular principles of gene transcription. This work could potentially lead to the development of new types of antibiotics that could target Rho and its crucial functions.
A study published in the January 13, 2010 issue of the Journal of Neuroscience links a loss of smell function in Alzheimer’s disease (AD) model animals with amyloid beta (protein) accumulation in the brain, a distinguishing hallmark of Alzheimer’s disease. Research conducted by NYU Langone Medical Center suggests that olfactory dysfunction, a common symptom of AD, may serve as an early diagnostic tool for the disease.
2010 marks the 25th year anniversary of the development of the ABCDEs acronym developed by dermatologists at NYU Langone Medical Center that provide criteria for diagnosing melanoma. One American dies every hour from melanoma, the deadliest of the major forms of skin cancer. If detected early, melanoma can be successfully treated.
Forgot where you put your car keys? Having trouble recalling your colleague’s name? If so, this may be a symptom of subjective cognitive impairment (SCI), the earliest sign of cognitive decline marked by situations such as when a person recognizes they can’t remember a name like they used to or where they recently placed important objects the way they used to. Studies have shown that SCI is experienced by between one-quarter and one-half of the population over the age of 65. A new study, published in the January 11, 2010, issue of the journal Alzheimer’s & Dementia, finds that healthy older adults reporting SCI are 4.5 times more likely to progress to the more advanced memory-loss stages of mild cognitive impairment (MCI) or dementia than those free of SCI.
Inheritance of an extra copy of the gene- ß -amyloid precursor protein, APP, in individuals with Down syndrome leads to the inevitable development of early onset Alzheimer’s disease, known to be linked to the deposition of Amyloid ß peptide or Aß in the brain. However, a new study published online in PNAS identifies ßCTF, a small protein found in APP, as a novel factor for the development of Alzheimer’s disease related endosome abnormalities, which have also been tied previously to the loss of brain cells in Alzheimer’s disease.
A new study published this week in the Journal of Neurosurgery: Pediatrics finds that operative plans for removing Juvenile Pilocytic Astrocytoma, or JPA, tumors in the thalamus of the brain can be augmented with Diffusion Tensor Imaging, or DTI. The sensitivity of DTI imaging allows for the visualization of nerve fiber bundles in the brain. This information can maximize the potential of completely removing the tumor while avoiding damage to the fiber bundles that are directly related to motor functions of the patient.
Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, according to a new study by NYU Langone Medicine Center researchers. The study is published online this week in the journal Nature.
NYU Langone Medical Center is the first hospital in the Northeast to offer one of the world’s fastest and most radiation dose efficient computed tomography (CT) scanner. The Siemens SOMATOM Definition Flash can image ten times as fast as other clinical units, with an up to 90% dose reduction in radiation compared to conventional imaging. The scanner’s dual source technology allows NYU Langone Medical Center to provide new levels of patient care, especially for trauma, pediatric, cancer and cardiac patients.
Some melanoma patients can live for years with cancer that has spread beyond the skin to other organs. Now it may be possible to identify which patients are more likely to survive, according to researchers at NYU Langone Medical Center.
A study published this week in PNAS provides a comprehensive comparative functional anatomy study in human and monkey brains which reveals highly similar brain networks preserved across evolution.
NYU Langone Medical Center (NYULMC) announced that Owen A. O’Connor, MD, PhD, has been appointed Deputy Director of Clinical Research and Cancer Treatment at The Cancer Institute (CI) and Chief of the new Division of Hematologic Malignancies and Medical Oncology in the department of Medicine.
Medical researchers have long suspected that obscure bacteria living within the intestinal tract may help keep the human immune system in balance. An international collaboration co-led by scientists at NYU Langone Medical Center has now identified a bizarre-looking microbial species that can single-handedly spur the production of specialized immune cells in mice.
NYU Langone Medical Center has received a five-year, $10 million grant from the National Institute of Mental Health (NIMH) to establish a Silvio O. Conte Center for the Neuroscience of Mental Disorders.
A new study recently published online by the American Heart Journal shows that more than half of all randomized clinical trials, or RCTs, for cardiovascular disease are not reporting vital information about the study populations race or ethnicity. NYU School of Medicine researchers found that out of the 156 cardiovascular disease RCTs analyzed, only 35% of trials reported any information on race or ethnicity between 1970 and 2006. From 2000 to 2006, 46% of trials included that information.
NYU Langone Medical Center has been awarded more than $30 million in research grants from the National Institute of Health (NIH) for 86 research projects being conducted at NYU School of Medicine across a broad range of basic science and clinical departments.
The Cancer Institute (CI) at NYU Langone Medical Center (NYULMC) announced today that Lori Fink has been appointed Chair of its Board of Directors. She joined the CI Board in 2008. In her new position, Fink will take an active leadership role at the CI, including helping to set the strategic direction of the CI. Fink will also work closely with the NYU Langone Medical Center Board of Trustees, Dean and senior leadership to help advance the mission of the Cancer Institute.
A new study published in the September 15, 2009, issue of PLoS ONE found that patients with cavitary pulmonary tuberculosis receiving anti-TB medications supplemented with nebulized interferon-gamma have fewer bacilli in the lungs and less inflammation, thereby reducing the transmissibility of tuberculosis in the early phase of treatment.
A new study published in the September 11, 2009 issue of Science by researchers at the NYU School of Medicine reveals a conceptually novel mechanism that plays an important role in making human pathogens like Staphylococcus aureus and Bacillus anthracis resistant to numerous antibiotics.
The Rusk Institute of Rehabilitation Medicine and the Hospital for Joint Diseases at NYU Langone Medical Center have both been re-accredited for a three-year period by the Commission of Accreditation of Rehabilitation Facilities (CARF), an international accrediting body focused on helping organizations measure and improve the quality of their programs and services. The accreditations awarded to both facilities recognize the Medical Center’s success in delivering high-caliber patient-centered care and validate that our organization conforms to nationally and internationally accepted service standards.
A new study from NYU School of Medicine found that women may have a slightly higher risk of death than men in the thirty days following an acute coronary syndrome (ACS), but that these differences appear to be attributable to factors such as severity and type of ACS. The study, published in the August 26, 2009 issue of the Journal of the American Medical Association (JAMA), found however that overall there was no significant difference in mortality observed between the sexes after a heart attack. The large observational study pooled 136,247 ACS patients from 11 independent, international randomized clinical trials between 1993 and 2006.
Six NYU School of Medicine physicians are among the first in the country to be certified by the American Board of Addiction Medicine, a new independent medical specialty board. The American Board of Addiction Medicine (ABAM) will certify physicians from several specialties, including emergency medicine, family medicine, internal medicine, obstetrics and gynecology, pediatrics, preventive medicine, psychiatry, neurology and surgery as addiction specialists.
Gastroesophageal reflux diseases, or GERD, affects about 10 million people in the United States, yet the cause and an unexpected increase in its prevalence over the last three decades remains unexplainable. Now, researchers have discovered that GERD is associated with global alteration of the microbiome in the esophagus.
July is Ultraviolet light (UV) Safety Awareness Month. Lisa Park, MD, clinical assistant professor in the department of ophthalmology at NYU Langone Medical Center is urging Americans this summer to protect their eyes from the harmful rays of the sun.
The Center of Excellence (COE) on Brain Aging at NYU Langone Medical Center inaugurates a new facility this week at 145 East 32 Street. The state-of-the-art, 15,000 square foot facility empowers collaboration, uniting the COE's existing clinical care centers with well-established clinical research programs focused on healthy brain aging, Alzheimer's disease, Parkinson disease, and other neurodegenerative cognitive disorders.
NYU and NYU School of Medicine received a $29.4 million, five-year Clinical and Translational Science Award from the National Institutes of Health (NIH) to establish a University-wide Clinical & Translational Science Institute (CTSI) in partnership with the New York City Health and Hospitals Corporation (HHC). The funding is designed to train medical researchers, more rapidly advance science from the lab to the patient to the community and to allow researchers to explore mechanisms of health disparities and develop evidence-based approaches targeted at their reduction.
NYU Langone Medical Center announced today a $100 million gift from the Druckenmiller Foundation to establish a state-of-the-art neuroscience institute at the Medical Center.
A protein called STAT3 has been found to play a fundamental role in converting normal cells to cancerous cells, according to a new study led by David E. Levy, Ph.D., professor of pathology and microbiology at NYU Langone Medical Center. The study, published in the June 26th issue of the journal Science, found that STAT3, in addition to its role in the cell nucleus regulating gene expression, is also present in mitochondria and regulates the activity of the electron transport chain in tumors cells.
Two NYU Langone Medical Center researchers have received $1,560,000 in grant support for their first year of studies focused on microbiome and psoriasis and on microbiome and esophageal cancer from the National Institutes of Health (NIH). The studies being conducted at NYU Langone Medical Center are two of several projects being conducted through the NIH Roadmap for Medical Research as part of the Human Microbiome Project (HMP) taking place at institutions across the country.
A new study reveals the molecular agents behind the devastating infiltration of leukemic cells into the brain and spinal cord of children with T-cell acute lymphoblastic leukemia (T-ALL) who relapse following chemotherapy and radiation treatments.
Aggressive, deadly and often misdiagnosed, inflammatory breast cancer (IBC) is the most lethal form of primary breast cancer, often striking women in their prime and causing death within 18 to 24 months. Now, scientists from The Cancer Institute at NYU Langone Medical Center have identified a key gene"”eIF4G1"”that is overexpressed in the majority of cases of IBC, allowing cells to form highly mobile clusters that are responsible for the rapid metastasis that makes IBC such an effective killer.
UnitedHealthcare, a UnitedHealth Group (NYSE: UNH) company, has signed an expanded, multi-year agreement with the physicians of the Hospital for Joint Diseases (HJD) at NYU Langone Medical Center that doubles the number of orthopedic physicians participating in UnitedHealthcare and Oxford Health Plans' provider network in New York City.
A new study published online in Nature Immunology ahead of the June 2009 print issue has found that homologous immunoglobulin (lg) alleles pair up in the nucleus at stages that coincide with V(D)J recombination of the heavy and light chain (Igh and Igk) loci.
The Critical Care Center, a new cutting edge, spacious, patient and family centered intensive care unit was unveiled on the 15th floor of Tisch Hospital at NYU Langone Medical Center. The first patients will begin being treated at the Center on May 18, 2009.
The following news tips are based on abstracts or posters to be presented at the annual meeting of the American Society of Clinical Oncology (ASCO) in Orlando, Florida, May 29 "“ June 2, 2008.
Graduation for the 168th class of the NYU School of Medicine will take place on Thursday, May 14, 2009 at Avery Fisher Hall at Lincoln Center Plaza in New York City. The class of 2009 comprises 80 women and 84 men, ranging from early 20s to mid 40s who come from 26 different states, Puerto Rico and Canada. Of the 164 graduates, 32 will remain at NYU for their residency and 76% received appointments at the top 50 medical schools.
Young children whose parents are active participants in their development by reading, talking, teaching and playing at every opportunity help their children become better prepared for school.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right